SEC Form 4 · accession 0001562180-19-001488
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis Matis
Officer — Chief Development Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.09 | Feb 26, 2019 | A | 96,500 | A | — | Feb 26, 2029 | Common Stock | 96,500 | 96,500 | D |
Explanation of responses
- F1The option vests as to 25% of the option shares on February 26, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.